Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16148
mi
from
Clearwater, FL
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16148
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16003
mi
from
Jacksonville, FL
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16003
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16144
mi
from
Atlanta, GA
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16144
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16112
mi
from
Boise, ID
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16112
mi
from
Boise, ID
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16060
mi
from
Evanston, IL
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16060
mi
from
Evanston, IL
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16179
mi
from
Elkhart, IN
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16179
mi
from
Elkhart, IN
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16102
mi
from
Indianapolis, IN
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16102
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16025
mi
from
West Des Moines, IA
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16025
mi
from
West Des Moines, IA
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16004
mi
from
Lexington, KY
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16004
mi
from
Lexington, KY
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16004
mi
from
Lexington, KY
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16004
mi
from
Lexington, KY
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16016
mi
from
Louisville, KY
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16016
mi
from
Louisville, KY
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16208
mi
from
Alexandria, LA
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16208
mi
from
Alexandria, LA
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16062
mi
from
Auburn, ME
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16062
mi
from
Auburn, ME
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16079
mi
from
Bangor, ME
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16079
mi
from
Bangor, ME
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16031
mi
from
Baltimore, MD
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16031
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16028
mi
from
Detroit, MI
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16028
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16061
mi
from
Petoskey, MI
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16061
mi
from
Petoskey, MI
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16211
mi
from
Minneapolis, MN
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16211
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16234
mi
from
St. Paul, MN
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16234
mi
from
St. Paul, MN
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16063
mi
from
Tupelo, MS
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16063
mi
from
Tupelo, MS
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16033
mi
from
Brooklyn, NY
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16033
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16174
mi
from
Buffalo, NY
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16174
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site - 16213
mi
from
New York, NY
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site - 16213
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16056
mi
from
Durham, NC
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16056
mi
from
Durham, NC
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16201
mi
from
Elizabeth City, NC
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16201
mi
from
Elizabeth City, NC
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16014
mi
from
High Point, NC
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16014
mi
from
High Point, NC
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16024
mi
from
Winston-Salem, NC
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16024
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16047
mi
from
Cincinnati, OH
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16047
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16026
mi
from
Hershey, PA
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16026
mi
from
Hershey, PA
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16100
mi
from
Lancaster, PA
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16100
mi
from
Lancaster, PA
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16017
mi
from
Philadelphia, PA
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16017
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16039
mi
from
Greenwood, SC
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16039
mi
from
Greenwood, SC
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16018
mi
from
Rapid City, SD
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16018
mi
from
Rapid City, SD
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16202
mi
from
Greeneville, TN
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16202
mi
from
Greeneville, TN
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16015
mi
from
Amarillo, TX
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16015
mi
from
Amarillo, TX
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16099
mi
from
Dallas, TX
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16099
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16241
mi
from
Wichita Falls, TX
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16241
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16038
mi
from
Richmond, VA
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16038
mi
from
Richmond, VA
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 16166
mi
from
Wausau, WI
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 16166
mi
from
Wausau, WI
Click here to add this to my saved trials
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated:  12/13/2016
Study Site 10002
mi
from
Herston,
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.
Status: Enrolling
Updated: 12/13/2016
Study Site 10002
mi
from
Herston,
Click here to add this to my saved trials
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/15/2016
Lake Washington Vascular, Pllc
mi
from
Bellevue, WA
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/15/2016
Lake Washington Vascular, Pllc
mi
from
Bellevue, WA
Click here to add this to my saved trials
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/15/2016
PeaceHealth St. Joseph Medical Center
mi
from
Bellingham, WA
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/15/2016
PeaceHealth St. Joseph Medical Center
mi
from
Bellingham, WA
Click here to add this to my saved trials
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/15/2016
St. Francis Hospital
mi
from
Federal Way, WA
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/15/2016
St. Francis Hospital
mi
from
Federal Way, WA
Click here to add this to my saved trials
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/15/2016
Good Samaritan Hospital
mi
from
Puyallup, WA
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/15/2016
Good Samaritan Hospital
mi
from
Puyallup, WA
Click here to add this to my saved trials
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/15/2016
Harborview Medical Center
mi
from
Seattle, WA
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/15/2016
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/15/2016
Northwest Hospital and Medical Center
mi
from
Seattle, WA
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/15/2016
Northwest Hospital and Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/15/2016
Providence Sacred Heart Medical Center
mi
from
Spokane, WA
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/15/2016
Providence Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/15/2016
Tacoma General Hospital
mi
from
Tacoma, WA
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/15/2016
Tacoma General Hospital
mi
from
Tacoma, WA
Click here to add this to my saved trials
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/15/2016
St. Joseph Medical Center
mi
from
Tacoma, WA
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/15/2016
St. Joseph Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/15/2016
Providence Everett
mi
from
Everett, WA
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/15/2016
Providence Everett
mi
from
Everett, WA
Click here to add this to my saved trials